Dopaminerge lægemidler til behandling af depression
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Dopaminerge lægemidler til behandling af depression. / Burmester, Daniel; von Buchwald, Carl Michael; Videbech, Poul.
I: Ugeskrift for Laeger, Bind 183, Nr. 47, 22.11.2021.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Dopaminerge lægemidler til behandling af depression
AU - Burmester, Daniel
AU - von Buchwald, Carl Michael
AU - Videbech, Poul
PY - 2021/11/22
Y1 - 2021/11/22
N2 - A significant proportion of patients with depression do not respond to classic antidepressants addressing serotonergic or noradrenergic neurotransmission. Certain clinical features of depression seem to involve dopaminergic neurotransmission. Although medications with specific dopaminergic actions are used in the treatment of depression in other countries (e.g. the United States), these drugs are rarely mentioned in Danish treatment guidelines. This review aims at comprehending current dopaminergic treatment strategies and future directions in this field.
AB - A significant proportion of patients with depression do not respond to classic antidepressants addressing serotonergic or noradrenergic neurotransmission. Certain clinical features of depression seem to involve dopaminergic neurotransmission. Although medications with specific dopaminergic actions are used in the treatment of depression in other countries (e.g. the United States), these drugs are rarely mentioned in Danish treatment guidelines. This review aims at comprehending current dopaminergic treatment strategies and future directions in this field.
KW - Antidepressive Agents/therapeutic use
KW - Depression/drug therapy
KW - Dopamine
KW - Dopamine Agents
KW - Humans
KW - Norepinephrine
M3 - Tidsskriftartikel
C2 - 34851261
VL - 183
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 47
ER -
ID: 305549600